skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine (Code C74057)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Definition: A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from malignant glioma cells with potential immunostimulatory and antineoplastic activities. Upon administration, malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine exposes the immune system to undefined malignant glioma tumor-associated antigens (TAAs), which may result in anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against glioma cells and glioma cell lysis.

Display Name: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

Label: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

NCI Thesaurus Code: C74057 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383942  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 584589
PDQ Open Trial Search ID 584589 (check for NCI PDQ open clinical trial info)
NCI META CUI CL383942

Other Properties:
     Name Value (qualifiers indented underneath)
code C74057
Contributing_Source CTRP
Legacy_Concept_Name Malignant_Glioma_Tumor_Lysate-Pulsed_Autologous_Dendritic_Cell_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74057

Mainbox Bottom